Long term follow-up of EGFR mutated NSCLC cases

PURPOSE: A substantial fraction of all non-small cell lung cancers(NSCLC) carry a mutation in the EGFR gene for which an effective treatment with anti-tyrosine kinases(TKIs) is available. We studied the long term survival of these patients following the introduction of TKIs. EXPERIMENTAL DESIGN: All...

Descripción completa

Detalles Bibliográficos
Autores principales: Rennert, Gad, Gottfried, Maya, Rennert, Hedy S, Lejbkowicz, Flavio, Frank, Meira, Cohen, Ilana, Kelt, Shiri, Agbarya, Abed, Dudnik, Elizabeta, Dudnik, Julia, Katznelson, Rivka, Mishali, Moshe, Maimon Rabinovich, Natalie, Nechushtan, Hovav, Onn, Amir, Keren Rosenberg, Shoshana, Wollner, Mariana, Zer, Alona, Bar, Jair, Gronich, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658494/
https://www.ncbi.nlm.nih.gov/pubmed/33186889
http://dx.doi.org/10.1016/j.tranon.2020.100934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658494/
https://www.ncbi.nlm.nih.gov/pubmed/33186889
http://dx.doi.org/10.1016/j.tranon.2020.100934

Ejemplares similares